Solteq’s Q4 results were weaker than expected. While the company maintained its profitability improv...
Raute has already achieved high results, and they could be even higher in a more favorable market en...
CapMan’s Q4 results were better than expected through good investment returns.
Finnair’s results were very strong for Q4 after some more challenging quarters last year.
Small signs pointing towards a system-wide deal in India At the presentation of the Q4’24 report, C...
Endomines is progressing well in line with its strategy and the H2/24 was clear evidence of the comp...
Umida Group publicerade den 13 februari 2025 bolagets delårsrapport för det fjärde kvartalet år 2024...
EBIT in line with preliminary figures, sales slightly above Formpipe has taken measures to enhance m...
Redeye comments on Formpipe’s Q4, with a soft adjusted EBIT as previously announced.
Redeye states Acconeer’s net sales came in below expectations, driven by a postponement of a prepaid...
Redeye's provides its initial take on Genovis' year-end report which came in softer than we had esti...
Redeye provides an initial comment on Safeture’s Q4 2024 report, which showed slower ARR growth than...
Redeye interviews Mentice’s CEO Frans Venker and CFO Ulrika Drotz Voksepp.
Redeye comments on SHH´s fourth quarter. SSH posted a growth of 23% Y/Y, and EBITDA margin of 25%.
Minor estimate changes Potential start of variable revenue acceleration EV/ARR 2x, '25e EV/EBITDA ~8...
Redeye states that BeammWave’s report was unsurprising.
Redeye provides an update on Acarix following its year-end report, which showed softer-than-expected...
Redeye updates on Invisio following its strong Q4-results and a continued positive outlook for 2025E...
Redeye comments on Alligator Bioscience's Q4 report and the rights issue, which was subscribed to 54...
Relais' Q4 report was above LSEG consensus expectations, supported by strong 9% y/y organic revenue ...